Thursday, March 26, 2009

Methylphenidate vs. Atomoxetine ADHD Medications: Effects on Sleep

Stimulants are often the primary source of medication for ADHD and related disorders. Medications such as methylphenidate (Ritalin, Concerta, Daytrana), Adderall, Vyvanse and the like are often the first line of defense and choice of prescription for ADHD for many practicing physicians. However, certain drawbacks exist to these medications. Perhaps the three most common concerns are cardiovascular effects, stimulant induced sleep difficulties, and appetite suppression and resulting weight loss.


As a result, some parents and prescribing physicians choose a non-stimulant form of medication for treating ADHD such as Atomoxetine (Strattera). While some of the negative side effects mentioned above are less common for these non-stimulant options, the overall efficacy of reducing core ADHD symptoms is often less extensive than for the stimulant counterparts.

In this post, we will investigate one of the problem areas of stimulant medication by examining a handful of studies comparing and contrasting the different effects of methylphenidate and atomoxetine on sleep patterns in ADHD individuals. Sleep patterns are often analyzed via reports (either the patients themselves, or parents if the patient is a child), actigraphy (less invasive) or polysomnography (more details and quantitative data).


Methylphenidate:

Adult ADHD studies on methylphenidate and sleep quality:
While sleep difficulties are clearly evident in several studies, numerous others have actually shown overall positive effects of methylphenidate on sleep performance. For example, a study by Boonstra and colleagues on sleep activity patterns in adult ADHD showed that methylphenidate administration resulted in a delayed period of sleep onset. However, once subjects did fall asleep, the frequency of nighttime awakenings decreased significantly for the methylphenidate group (keep in mind that all of these individuals had ADHD), and that the overall duration of sleep for the night was less for the methylphenidate participants. These positive results were echoed in a study by Sobanski and coworkers, which found that methylphenidate administration improved efficiency and restorative quality in adults with ADHD compared to non-medicated individuals with the disorder. In other words, it appears that although methylphenidate can delay the onset of sleep, it appears to offer a positive effect in promoting a deeper pattern of less-interrupted sleep in ADHD adults.


ADHD, Methylphenidate and Sleep Quality in Children:

One of the difficulties in assessing the effects of ADHD medications on sleep deficits in children is that it relies heavily on parental reports and observations. Unfortunately, the overall accuracy of these parental (as well as teacher ratings) has been called in to question by several recent findings. More info on this is given at the bottom of the post.

Another key issue, is the relative lack of long-term controlled studies on methylphenidate in children due to a myriad of safety and practicality issues. As a result, obtaining clear-cut and accurate information on ADHD stimulant medications and sleep disorders in children is more tenuous than in the adult model, even though the overall number of studies on ADHD medication effectiveness is much higher in children. In other words, sleep disorders still hold a relatively remote corner amongst the sea of information on pediatric ADHD.

Nevertheless, several studies on the matter have been done in the past few years. I will highlight some of them below:

An investigation by O'Brien and coworkers found a significant increase in sleep disturbances for ADHD children regardless of medication status. These findings suggest a neutral effect of stimulant medications such as methylphenidate for children with ADHD, but cite an often-overlooked characteristic: ADHD children typically exhibit more sleep difficulties than non-ADHD children. Therefore, some of the bad rap attributed to ADHD stimulant medications such as methylphenidate for inducing sleep disorders may simply be due to the nature of the individual's ADHD and not to the medication. This is an important observation to keep in mind, especially when investigating sleep medication studies.

There is even some evidence that the assertion of methylphenidate administration later in the day (afternoon) may negatively impact sleep performance is less pronounced than popularly believed. Many physicians fear that a third daily dose of methylphenidate may cause sleep difficulties and omit the afternoon dosage. However, a study by Kent indicates that this may not be the case. Of course this is just one study, and should be regarded as such, but this may at least open the possibility that a number of these afternoon medication/sleep impairment fears may be less grounded than previously believed. Nevertheless, sleep disturbances are still a concern with ADHD medications such as methylphenidate, but, according to recent findings, the effects are relatively small.


"Do genetics play a role on sleep disorders and the ADHD medication response?"

This is an intriguing question which needs to be investigated further. We have had several previous discussions on the COMT gene and its effects on ADHD. Now it appears that sleep disorders and potential medication response may actually be impacted by an individual variation in this hotbed region of the human genome. A study done by Gruber and coworkers suggests that ADHD children with the Val form of the COMT gene may be more prone to sleep difficulties while on methylphenidate compared to the Met form of the COMT gene (if you are unfamilar with this "Val", "Met" and "COMT" terminology, a good explanation of these terms and how they relate to ADHD and ADHD medications can be found here).

ADHD, Sleep Quality and Strattera (Atomoxetine) in children:

In contrast to methylphenidate, which seems to delay the onset of sleep, individuals on atomoxetine have a much smaller delay in sleep onset. These differences were highlighted in an article by Sangal and coworkers titled Effects of Atomoxetine and methylphenidate on sleep in children with ADHD. Other advantages of atomoxetine over methylphenidate include less irritability, less difficulty getting ready for bed, less difficulty waking up in the morning, and less of an appetite suppression. However, the postive effects of fewer nighttime awakenings seen in methylphenidate were not observed in atomoxetine.

Methylphenidate vs. Atomoxetine: Comparative Effects on Sleep

Here are some of the highlights obtained from the Sangal study. A number of parameters and categories were investigated, but I have only included ones which were either statistically significant or ones which I personally found to be noteworthy:

A comparison of differences between Atomoxetine (Atom) and Methylphenidate (MPH), as well as the effects of both medications compared to unmedicated ADHD individuals are shown above. Quantitative measurements were performed using both polysomnography (polysom) and actigraphy. Some key trends of note:

  • A delayed onset of sleep was seen in Methylphenidate.
  • However, REM sleep (an important factor in overall sleep quality) was reached faster with Methylphenidate and slower with Atomoxetine.
  • Additionally, a slight increase in the percentage of sleep time spent in REM was seen with methylphenidate treatment.
  • Fewer sleep disruptions (partial or full, as in awakenings) were seen with both medications, but the effects were even greater in the methylphenidate group.
  • When a child did awaken during the sleep cycle, the children medicated with methylphenidate were able to fall back asleep much faster. Note this contrast to the increased time to fall asleep initially for the methylphenidate group.
Overall, it appears that while methylphenidate does slow the onset of sleep initially at a significant level, it appears that once a child does fall asleep, the overall sleep quality is actually improved if the child is medicated with methylphenidate. This data runs against the grain as far as prescription medications for ADHD are concerned, in which nonstimulants such as Strattera (Atomoxetine) are often given in favor of stimulants such as methylphenidate if sleep disorders are a concern. This is likely due to the most obvious parameter (initial difficulty falling asleep), which favors Strattera, while the other parameters, which favor methylphenidate and are more numerous, are less intrinsically obvious.

Why the pronounced difference between the two ADHD medications?

While there is still a fair amount of debate surrounding the exact cause of different impacts of these ADHD medications on sleep, the different biological targets and modes of action may offer some clues. For example, while methylphenidate primarily targets the neuro-signaling agent dopamine in brain regions such as the striatum and nucleus accumbens, Strattera (atomoxetine) instead targets another neurotransmitter called norepinephrine.

It appears that the different neurochemical targets and specific brain regions impacted by the two medications are responsible for the differences. For example, we have previously mentioned in another post on gene variations and attention control that the cingulate region of the brain, which essentially acts as the brain's gear shifter, has a high density of receptors for dopamine, the very chemical that methylphenidate targets. It is possible that changes in dopamine levels from methylphenidate may indirectly impact the "gear shifting" ability of the key brain region of the cingulate. We have previously discussed that an overactive cingulate region can lead to difficulties changing focus or transitioning between topics or activities, while an underactive cingulate can lead to difficulty maintaining focus on a particular thought or state.

Putting this into context of our sleep and ADHD medication discussion, it is also worth noting that the Sangal paper mentioned that children who took the methylphenidate had a more difficult time getting up in the morning and settling down into a pre-bedtime routine than the Strattera group. In other words, it seems like the methylphenidate group had trouble with transitions. As a result, this blogger hypothesizes that the transitions may be caused, at least in part, by the increased activity of the cingulate region of the brain and it's high density of dopamine targets, which see increased activities driven by a boost in free dopamine levels from the methylphenidate. In other words, I suggest the possibility that methylphenidate induces a state of the cingulate "gear" shifter becoming overactive and getting stuck in one routine (either the waking or sleeping state) and having trouble moving to another (getting out of bed or falling asleep). Further supporting this hypothesis is the data from the table above showing that the methylphenidate treatment group appears to be more inert (i.e. fewer sleep interruptions, and a quicker return to a previous sleeping state).

Inconsistencies between parent and teacher reports and actigraphic studies for sleep in ADHD children:

Finally, it is worth noting that the different methods of sleep data acquistion are far from perfect. It appears that there is at least some discord between the methods of measurement.

Compounding the problem of sleep disorders in children is the relative inconsistency between parental reports of sleep disturbances and disorders and results derived from actigraphic studies. This appears to be a recurring problem in the literature, and is confirmed by several other studies of observation. Additionally, teacher evaluations may also be flawed with regards to sleep disorders and ADHD-like behaviors.

Final notes on the methylphenidate vs. atomoxetine debate on ADHD and sleep:

While the current trends in medication prescription still shy away from stimulants such as methylphenidate for fear of insomnia, the findings of some of the recent studies show that overall sleep quality in ADHD individuals may actually improve (in spite of the initial sleep delays) with methylphenidate treatments instead of non-stimulant medications such as Strattera. I personally anticipate further sleep studies in the near future which will confirm several of these findings.

Add to Technorati Favorites

13 comments:

James said...

I think strattera is realy great treatment for the sleep problems

adult adhd physicians Connecticut said...

I just read the article and I find it very interesting and educational as well. Knowing this truth is really a big help for all who have this kind of problem.

John Scott said...

Regardless of whether or not stimulant medications of any type actually result in difficulty sleeping or not, we need to remember too, that many "studies" affirming the positive effects of psychiatric drugs, are sponsored by the drug companies themselves, and designed in such a way so as to come up with the desired results. Additionally, studies sponsored by the pharmaceutical giants, which do not support what they are trying to prove, aren't published. Since most of the money for studies comes from the psychiatric drug industry, it casts doubts on the hair splitting conclusions reached tauting the safety and efficacy of the drugs. Treating ADHD without drugs is a better idea, is very possible, and why aren't there a ton of studies out there on the effectiveness of non-pharmaceutical treatments? Who is going to pay for a study on the benefit of walking in the park as a depression or ADHD treatment? So, there are some studies like that, but they are in the shadow of the continuous flow of studies sponsored by the pharmaceutical industry.

muebles en huelva said...

Pretty helpful material, thanks so much for the article.

www.tapicerias.nom.es said...

There's no doubt, the guy is completely right.

comprar viagra said...

Nice post I like your site very well and I continue visit on this site for more information.

viagra said...

Hi,
This type of cloth is the one every pregnant women need, somrthing that makes her look anazing

viagra review said...

Excellent post.I want to thank you for this informative read, I really appreciate sharing this great post. Keep up your work.

Rick Mayer said...

Psychostimulants and non stimulants are effective in the treatment of ADHD. Efficacy of both methylphenidate and atomoxetine has been established in placebo controlled trials. Direct comparison of efficacy is now possible due to availability of results from several head-to-head trials of these two medications.
Download and read this Ebook: ADD ADHD Advance for more info.
In general atomoxetine and methylphenidate have comparable efficacy and equal acceptability in treatment of ADHD in children and adolescents. However OROS methylphenidate is more effective than atomoxetine and may be considered as first line treatment in treatment of ADHD in children and adolescents.

Akami Ayurveda said...

I came across through your blog. I found the valuable information about ADHD treatment from your blog.
Ayurveda Detoxification Therapy

Joseph said...

The great content sharing through your blog. Thanks for sharing.
ayurvedic treatment for brain stroke

Emily Williams said...

For ADHD Medication Online, click these below links.

Buy Adderall Online
Buy Adderall 10mg Online
Buy Adderall 12.5mg Online
Buy Adderall 15mg Online
Buy Adderall 20mg Online
Buy Adderall 30mg Online
Buy Adderall 5mg Online
Buy Adderall 7.5mg Online

Anonymous said...

I want to share with you all on how Dr Itua saves my life with his powerful Herbal medicines, I was diagnosed of Oral/Ovarian Cancer which i suffered from for 5 years with no positive treatment until when My son came to me in the hospital when i was laying down on my dying bed waiting for god to call out my name to join him in heaven.
My son was so excited that very day he came across Dr Itua on Blogspot, we decided to give him a try although we Americans are so scared to trust Africans but i really have no choice that time to choose life in between so we gave a try to Dr Itua Herbal medicines, god wiling he was a good man with a god gift. Dr Itua send us the herbal medicine it was three bottles. I take it for three weeks instructor and this herbal medicines heal me, cure my Oral/Ovarian Cancer completely I have been living for 9 months now with healthy life no more symptoms.
I'm sponsoring Dr Itua in LA Advert on Cancer patent seminar which my son will be participating too and other patent Dr Itua has cured from all kind of human disease, also if you are sick from disease like,Epilepsy,Breast Cancer,Prostate Cancer,Throat cancer,Thyroid Cancer,Uterine cancer,Fibroid,Angiopathy, Ataxia,Arthritis,Brain cancer,Hiv,. Vaginal cancer,Herpes,Colon-Rectal Cancer,Chronic Disease.Amyotrophic Lateral Scoliosis,Brain Tumor,Fibromyalgia,Fluoroquinolone Toxicity,Multiple myeloma,Tach Diseases,Leukemia,Liver cancer,
Esophageal cancer,Gallbladder cancer,,Bladder cancer,Gestational trophoblastic disease,Head and neck cancer,Hodgkin lymphoma
Intestinal cancer,Kidney cancer,Hpv,Lung cancer,Adrenal cancer.Bile duct cancer,Bone cancer,Melanoma,Mesothelioma,Neuroendocrine tumors
Non-Hodgkin lymphoma,Cervical Cancer,Oral cancer,Hepatitis,Skin cancer,Soft tissue sarcoma,Spinal cancer,Pancreatic Cancer, Stomach cancer
Testicular cancer,
Syndrome Fibrodysplasia Ossificans ProgresSclerosis,Alzheimer's disease,Chronic Diarrhea,Copd,Parkinson,Als,Adrenocortical carcinoma Infectious mononucleosis,Vulvar cancer,Ovarian cancer,,Sinus cancer, Here Is The Wonderful Healer Contact. Name_ Doctor Itua, Email Contact: drituaherbalcenter@gmail.com, Phone/WhatsApp: +2348149277967